p32 promotes melanoma progression and metastasis by targeting EMT markers, Akt/PKB pathway, and tumor microenvironmentSunita Sinha(Manipal Academy of Higher Education), Vivek Rai(Institute of Life Sciences)Cell Death and DiseaseOctober 28, 202110.1038/s41419-021-04311-5Cited by 23SaveCiteExport RISWatch citationsRelated PapersDeletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse|Diabetes|2010|175